Ken Griffin Heron Therapeutics, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.73 - $3.67 $26,296 - $55,784	15,200 Added 53.9%	43,400 $86,000
Q2 2024 Aug 14, 2024	BUY	$2.32 - $3.86 $8,352 - $13,896	3,600 Added 14.63%	28,200 $98,000
Q1 2024 May 15, 2024	SELL	$1.71 - $3.06 $7,524 - $13,464	-4,400 Reduced 15.17%	24,600 $68,000
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $12,474 - $42,042	23,100 Added 391.53%	29,000 $49,000
Q3 2023 Nov 14, 2023	SELL	$0.97 - $1.8 $10,573 - $19,620	-10,900 Reduced 64.88%	5,900 $6,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $2.88 $10,656 - $27,648	9,600 Added 133.33%	16,800 $19,000
Q1 2023 May 15, 2023	SELL	$1.51 - $3.25 $5,738 - $12,350	-3,800 Reduced 34.55%	7,200 $10,000
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $23,850 - $49,502	-10,600 Reduced 49.07%	11,000 $27,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $4,256 - $8,592	-1,600 Reduced 6.9%	21,600 $91,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $188M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.